Abstract

Ajay Kumar Oli^1*, Apoorva Jain¹, Nagaveni Shivshetty², Palaksha Kanive Javaregowda¹, Kelmani Chandrakanth.R³

DOI : http://dx.doi.org/10.13005/ojc/390205

The prevalence of neurological illnesses is a leading cause of mortality and disability is rising globally. It is the second greatest cause of death globally. Multiple years of life adjusted for incidence of death and disability (DALY), the sum of years of life lost (YLLs) and years lived with disability (YLDs) by age and sex, are used to classify 15 neurological illnesses. Alzheimer's, Parkinson's, a stroke, Huntington's disease, and epilepsy are a few of them. Therefore, it is crucial to design and create novel delivery systems that could transport the therapeutic medications or diagnostic tools needed to treat neurological illnesses. In this overview, we go through fresh methods for improving medication absorption by the central nervous system (CNS). The treatment of neurological diseases, particularly those with neurodegenerative features, has a significant deal of potential to be impacted by nanotechnology. According to a number of studies, neurodegenerative CNS illnesses have been successfully treated with nanomaterials. The most effective usage of nanomaterials is the treatment of CNS disorders, which improves the overall impact of the medication and highlights the significance of nanotherapeutics.

Central Nervous system; Liposomes; Neurological disorder; Nanoparticles; Stroke

[ View HTML Full Text]